James G. Conway

Regulation of tumour necrosis factor-α processing by a metalloproteinase inhibitor

Gerard M. McGeehan, J. David Becherer, Robert C. Bast et al. · Nature · 1994 · 571 citations

Inflammation, Metalloprotein, Chronic Inflammation +7

Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats.

Daniel S. Marsman, Russell C. Cattley, James G. Conway et al. · PubMed · 1988 · 356 citations

Lipid Peroxidation, Pathology, Redox Biology +20

Inhibition of colony-stimulating-factor-1 signaling<i>in vivo</i>with the orally bioavailable cFMS kinase inhibitor GW2580

James G. Conway, Brad McDonald, Janet H. Parham et al. · Proceedings of the National Academy of Sciences · 2005 · 252 citations · Full text

Relationship of oxidative damage to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and Wy-14,643

James G. Conway, Konrad E. Tomaszewski, Michael J. Olson et al. · Carcinogenesis · 1989 · 120 citations

Glutathione Concentrations, Lipid Peroxidation, Oxidative Damage +18

Inhibition of cartilage and bone destruction in adjuvant arthritis in the rat by a matrix metalloproteinase inhibitor.

James G. Conway, Jean A. Wakefield, Roger H. Brown et al. · The Journal of Experimental Medicine · 1995 · 108 citations · Full text

Matrix Metalloproteinase Inhibitor, Sclerostin, Adjuvant Arthritis +16